Rheumatology is the branch of medicine devoted to the diagnosis and therapy of rheumatic diseases.
Rheumatologists deal mainly with clinical problems involving joints, soft tissues, autoimmune diseases, vasculitis and connective tissue disorders. Because the immune system is involved in many of these diseases rheumatology is increasingly the study of immunology.
There are over 200 types of rheumatic diseases and our rheumatology team offers a service of treatment to include rheumatoid, psoriatic and reactive arthritis, connective tissue disorders such as lupus (SLE), scleroderma and Sjögrens syndrome, vasculitis (including Wegener’s granulomatosis, polyarteritis nodosa, giant cell/temporal arteritis and Behçets syndrome), polymyalgia rheumatica, osteoporosis, ankylosing spondylitis and gout.
As rheumatic disease not only affects joints, the consultants work closely with their colleagues in orthopaedics, ophthalmology, neurology, ENT, thoracic and renal medicine in the treatment of their patients. They will refer patients to orthopaedic surgeons if treatment is needed, such as joint replacement. However, in recent years, better management of rheumatic disease has meant a reduction in the number of patients needing surgery.
The rheumatology team sees around 1,700 new outpatients and 6,000 follow-up patients per year within the Trust’s geographical area, as well as some patients from the East Grinstead area. Our outpatient clinics are held on several sites: East Surrey Hospital, Crawley Hospital, Horsham Hospital, Caterham Dene Hospital and Oxted Health Centre.
The rheumatology team has close links with the extended scope physiotherapy service, benefits from the cooperation of GP colleagues to facilitate safe prescribing and monitoring of rheumatology medications and has excellent and impeccable support from a team of experienced senior medical secretaries and administrative staff.
The rheumatology team and their patients are actively involved in clinical trials and research, both nationally and multi-nationally. Clincial trials ensure not only best quality clinical care but also patient access to the most up to date treatments.
Our clinical trials
- Outcome and delays in treating early arthritis
- Regular and ongoing contributions to the British Society for Rheumatology Rheumatoid Arthritis Register (BSRBR-RA) which is the largest prospective register in the world of rheumatology patients receiving biologic therapy. The chief aim of the register is to monitor the long-term safety profile of the biologic agents used
- ACTION Clinical Trial: a global study comparing anti-TNFα inhibitors with Tocilizumab as the first biologic treatment for rheumatoid arthritis
Rheumatology nurse specialists
T: 01293 600 300 x3417
T: 01737 768 511 x6748
Osteoporosis nurse specialist
T: 01737 768 511 x2835